Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers

NCT02725112 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pregabalin ER
DRUG: Pregabalin ER
DRUG: Pregabalin ER
DRUG: Pregabalin ER
DRUG: Pregabalin ER
DRUG: Pregabalin ER

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.